Ignite Creation Date:
2024-05-06 @ 7:13 PM
Last Modification Date:
2024-10-26 @ 3:02 PM
Study NCT ID:
NCT05937295
Status:
RECRUITING
Last Update Posted:
2023-09-29
First Post:
2023-05-09
Brief Title:
FusionVAC22_01 Fusion Transcript-based Peptide Vaccine Combined With Immune Checkpoint Inhibition
Sponsor:
University Hospital Tuebingen
Organization:
University Hospital Tuebingen
Organization Data
Organization:
University Hospital Tuebingen
Class:
OTHER
Study ID:
FusionVAC22_01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University Hospital Tuebingen
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None